Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103319455B reveals a novel route for high-purity Strontium Ranelate. Discover cost-effective catalytic strategies and scalable purification for API manufacturing.
Patent CN106928222A reveals a TEMPO-catalyzed route for 3-alkylindolizine derivatives offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel antitumor derivative synthesis offers mild conditions and high safety for scalable pharmaceutical intermediate manufacturing supply chains.
Novel piperazine side chain pleuromutilin derivatives offering lower cost and high purity for pharmaceutical manufacturing supply chains globally.
Patent CN113322291A details an enzymatic route for high-purity chiral amino alcohols, offering cost-effective solutions for veterinary antibiotic manufacturing.
Patent CN111100067A details a novel 3-step synthesis for a critical chlorpheniramine maleate impurity, enabling precise quality control and cost reduction in API manufacturing.
Novel water-based resolution method for R-tetrahydropapaverine ensures high purity and cost efficiency for cisatracurium besilate manufacturing.
Patent CN111094557B details novel ADH mutants enabling cost-effective, high-ee biocatalytic synthesis of chiral biaryl alcohols for antihistamine drugs.
Patent CN114181274B reveals a novel mixed-base catalyzed method for stable enolization and ethylidene reactions, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel patent method reduces cost and pollution for high-purity pharmaceutical intermediate manufacturing ensuring supply chain stability.
Patent CN106892832B details a high-purity Sitagliptin impurity synthesis. This method offers significant cost reduction in pharma manufacturing and reliable supply chain continuity.
Analysis of CN100445275C reveals a high-yield acyl chloride route for repaglinide. Discover cost-effective manufacturing strategies and supply chain advantages for this key antidiabetic API intermediate.
Novel copper-catalyzed method for N-sulfonyl sulfoximine derivatives. High yield, scalable process for pharmaceutical intermediates supply chain.
Patent CN101824017B details high-purity Scutellarein synthesis via acid hydrolysis. Offers scalable pharmaceutical intermediates manufacturing with enhanced yield and purity.
Explore patented synthetic methods for carfilzomib intermediates. Enhance supply chain reliability and reduce manufacturing costs with scalable pharmaceutical intermediate solutions.
Advanced method for N-(3-methyl-8-quinoline sulfonyl)-N-nitryl-L-arginine. Solves moisture control issues for scalable API manufacturing.
Patent CN113173894A enables green continuous production of tetrahydrofuran-3-one. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN111892488A reveals a novel Friedel-Crafts route for high-purity Crizotinib intermediates, offering significant cost reduction and scalable manufacturing solutions.
Patent CN111574475B details a novel synthesis route for RSV drug intermediates, offering improved solubility and cost reduction in API manufacturing through optimized catalytic steps.
Patent CN101935309B reveals a high-yield route for ezetimibe intermediates using a tricyclic indene oxazole auxiliary, offering superior stereoselectivity and cost-effective manufacturing solutions.